FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Asparaginase Erwinia Chrysanthemi (Erwinaze)
Status: Currently in Shortage
»Date first posted: 10/14/2016
»Therapeutic Categories: Hematology; Oncology; Pediatric

Expand all

Jazz Pharmaceuticals, Inc. (Revised 09/06/2019)

Company Contact Information:
800-520-5568

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
ERWINAZE 10,000 IU lyophilized powder supplied in a clear 3 mL glass vial 5 vial carton (NDC 57902-249-05) Out of Stock. At this time we are unable to provide a specific date for the next anticipated availability in the U.S. market. Jazz will provide another update by the end of September 2019. Please continue to visit erwinazesupply.com for the most up-to-date information.

Dear Health Care Provider Letter

Other
ERWINAZE 10,000 IU lyophilized powder supplied in a clear 3 mL glass vial 1 vial (NDC 57902-249-01) Out of Stock. At this time we are unable to provide a specific date for the next anticipated availability in the U.S. market. Jazz will provide another update by the end of September 2019. Please continue to visit erwinazesupply.com for the most up-to-date information.

Dear Health Care Provider Letter

Other

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English